Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Fexofenadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | DRD3 | P35462 | 3/20 | 1.00 |
| ▸ | DRD2 | P14416 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.98 |
| ▸ | HTR2A | P28223 | 2/20 | 0.98 |
| ▸ | HTR2B | P41595 | 2/20 | 0.98 |
| ▸ | BLM | P54132 | 2/20 | 0.98 |
| ▸ | CNR1 | P21554 | 1/20 | 0.98 |
| ▸ | APEX1 | P27695 | 1/20 | 0.98 |
| ▸ | PDE4A | P27815 | 1/20 | 0.98 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.98 |
| ▸ | CYP2J2 | P51589 | 3/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | NPC1 | O15118 | 1/20 | 0.79 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.79 |
| ▸ | GMNN | O75496 | 1/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fexofenadine SCHEMBL29562068 | 1.00 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL40914 | 1.00 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL3543634 | 0.99 | HRH1 (0.98) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL1395627 | 0.99 | HRH1 (0.98) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL48729 | 0.99 | HRH1 (0.98) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL1972366 | 0.99 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL1561082 | 0.99 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL3178320 | 0.99 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL4901 | 0.99 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 | |
| Fexofenadine SCHEMBL4900 | 0.99 | HRH1 (1.00) | HRH1LMNADRD3DRD2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6061 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12390416-B2 | Chewable pharmaceutical dosage forms | USpharma Ltd (US) | 2025-08-19 | — | — | US | claimed |
| CN-118436646-B | Application of fexofenadine hydrochloride in preparation of anti-fibrosis drugs | 浙江大学 | 2025-04-15 | — | — | CN | claimed |
| US-20250082623-A1 | COMPOSITIONS CONTAINING FEXOFENADINE | OPELLA HEALTHCARE GROUP SAS (FR) | 2025-03-13 | — | — | US | claimed |
| CN-119185198-A | Fexofenadine hydrochloride oral suspension and preparation method thereof | 杭州泓友医药科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118715004-A | Containing fexofenadine fixed composition | 欧彼乐医疗集团公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118436646-A | Application of fexofenadine hydrochloride in preparation of anti-fibrosis drugs | 浙江大学 | 2024-08-06 | — | — | CN | claimed |
| CN-118425395-A | Method for measuring fexofenadine hydrochloride tablet related substances | 成都市药品检验研究院 | 2024-08-02 | — | — | CN | claimed |
| US-20240226000-A9 | TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS | DYVE BIOSCIENCES, INC. | 2024-07-11 | — | — | US | claimed |
| CN-118286163-A | Fexofenadine hydrochloride dry suspension and preparation method thereof | 桂林华信制药有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118225926-A | Determination method of fexofenadine hydrochloride tablet in-vitro dissolution curve | 成都市药品检验研究院 | 2024-06-21 | — | — | CN | claimed |
| US-20020151504-A1 | STAT modulators | TULARIK INC. | 2002-10-17 | — | — | US | claimed |
| WO-2002060411-A2 | PROCESS FOR PRODUCTION OF NANOPARTICLES AND MICROPARTICLES BY SPRAY FREEZING INTO LIQUID | BOARD OF REGENTS UNIVERSITY OF TEXAS SYSTEM (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1185266-A4 | AMORPHOUS FORM OF FEXOFENADINE HYDROCHLORIDE | RANBAXY LAB LTD (IN) | 2002-07-17 | — | — | EP | claimed |
| WO-2002047607-A2 | PROCESS FOR THE PREPARATION OF A FAST DISSOLVING DOSAGE FORM | RANBAXY LABORATORIES LIMITED (IN) | 2002-06-20 | — | — | WO | claimed |
| WO-2002038107-A2 | STAT MODULATORS | TULARIK INC. (US) | 2002-05-16 | — | — | WO | claimed |
| EP-1185266-A1 | AMORPHOUS FORM OF FEXOFENADINE HYDROCHLORIDE | Ranbaxy Laboratories Limited (IN) | 2002-03-13 | — | — | EP | claimed |
| US-20020022639-A1 | Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrochloride | AVENTIS PHARMACEUTICALS INC. | 2002-02-21 | — | — | US | claimed |
| WO-2001085148-A2 | PACKAGING REGIMEN OF PSEUDOEPHEDRINE HYDROCHLORIDE AND FEXOFENADINE HYDROCLORIDE | AVENTIS PHARMACEUTICALS INC. (US) | 2001-11-15 | — | — | WO | claimed |
| WO-2001083517-A1 | STAT4 AND STAT6 BINDING DIPEPTIDE DERIVATIVES | TULARIK INC. (US) | 2001-11-08 | — | — | WO | claimed |
| WO-2000071124-A1 | AMORPHOUS FORM OF FEXOFENADINE HYDROCHLORIDE | RANBAXY LABORATORIES LIMITED (IN) | 2000-11-30 | — | — | WO | claimed |